ArticleSurgical endoscopy2026
Adjunctive fibrin glue for the prevention of bleeding after endoscopic submucosal dissection of gastroesophageal lesions: a systematic review and meta-analysis.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimBleeding after endoscopic submucosal dissection (ESD) is a relevant complication that may require urgent endoscopic intervention. Emerging evidence suggests that fibrin glue use after conventional hemostasis may reduce bleeding. This meta-analysis aimed to evaluate the association between fibrin glue use and the prevention of post-ESD ulcer bleeding in gastroesophageal lesions.
methodsPubMed, embase, and Cochrane CENTRAL were searched for randomized controlled trials (RCTs) and observational studies evaluating the use of fibrin glue as an adjunctive treatment after ESD for bleeding prevention. Outcomes were analyzed using risk ratios (RR) with 95% confidence intervals (CI), and heterogeneity was assessed using I
resultsSeven studies were included (2 RCTs and 5 observational studies), totaling 2141 patients who underwent ESD. Fibrin glue did not decrease the incidence of post-ESD overall bleeding in gastroesophageal lesions (RR: 0.67; 95% CI 0.29-1.57; p = 0.354; I
conclusionFibrin glue was not associated with a reduction in bleeding after ESD of gastroesophageal lesions. However, future studies should further evaluate its impact on high-risk subpopulations.
Indexed as
Identifiers
42622653What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.